| scholarly article | Q13442814 |
| P50 | author | Alberto Ambesi-Impiombato | Q71501192 |
| Elena Masiero | Q117812133 | ||
| P2093 | author name string | Giuseppe Basso | |
| Valeria Tosello | |||
| Paola Zanovello | |||
| Alberto Amadori | |||
| Roberta Bertorelle | |||
| Valeria Sacchetto | |||
| Sonia Minuzzo | |||
| Erich Piovan | |||
| Giorgia Pilotto | |||
| Fulvio Bordin | |||
| P2860 | cites work | The genetic basis of early T-cell precursor acute lymphoblastic leukaemia | Q24601515 |
| Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study | Q27851436 | ||
| Mutation of the Wilms' tumor 1 gene is a poor prognostic factor associated with chemotherapy resistance in normal karyotype acute myeloid leukemia: the United Kingdom Medical Research Council Adult Leukaemia Working Party | Q27851437 | ||
| Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia | Q27851659 | ||
| Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL. | Q27852067 | ||
| Puma is an essential mediator of p53-dependent and -independent apoptotic pathways | Q28213279 | ||
| Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus | Q28236741 | ||
| Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping | Q28236877 | ||
| DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia | Q28253465 | ||
| WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation | Q28255707 | ||
| WT-1 is required for early kidney development | Q28512266 | ||
| Physical and functional interaction between WT1 and p53 proteins | Q28575245 | ||
| Transcriptional control of human p53-regulated genes | Q29617650 | ||
| Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia | Q33733461 | ||
| Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia | Q33886181 | ||
| Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group. | Q34052581 | ||
| Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study | Q34052614 | ||
| Life, sex, and WT1 isoforms--three amino acids can make all the difference | Q34348689 | ||
| Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor | Q34557796 | ||
| Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse | Q35102275 | ||
| Natural IAP inhibitor Embelin enhances therapeutic efficacy of ionizing radiation in prostate cancer | Q35130362 | ||
| Analysis of TP53 mutation status in human cancer cell lines: a reassessment | Q35671197 | ||
| HGVS Recommendations for the Description of Sequence Variants: 2016 Update | Q35941614 | ||
| An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts | Q36751751 | ||
| A tumor suppressor and oncogene: the WT1 story. | Q36760031 | ||
| Mutation analysis of 24 known cancer genes in the NCI-60 cell line set. | Q37250634 | ||
| WT1 mutations in T-ALL | Q37291631 | ||
| Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia | Q37322911 | ||
| Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. | Q37351577 | ||
| WT1 in disease: shifting the epithelial-mesenchymal balance. | Q37940867 | ||
| Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1). | Q38220041 | ||
| A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer | Q39144862 | ||
| Design, synthesis, and characterization of new embelin derivatives as potent inhibitors of X-linked inhibitor of apoptosis protein | Q40233896 | ||
| Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database | Q40561637 | ||
| WT1-p53 interactions in insulin-like growth factor-I receptor gene regulation | Q40688483 | ||
| Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-κB inactivation | Q42182512 | ||
| The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. | Q45062542 | ||
| Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts. | Q45735200 | ||
| Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies. | Q47268104 | ||
| Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma. | Q51788134 | ||
| Recent advances in acute lymphoblastic leukemia. | Q53423186 | ||
| Cooperative genetic defects in TLX3 rearranged pediatric T-ALL. | Q53506137 | ||
| Wilms' tumor (WT1) gene mutations occur mainly in acute myeloid leukemia and may confer drug resistance. | Q54138925 | ||
| WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups. | Q54331723 | ||
| Clinical relevance of molecular aberrations in paediatric acute myeloid leukaemia at first relapse. | Q54342441 | ||
| Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: biological and clinical implications | Q59194331 | ||
| Genetic interactions between the Wilms' tumor 1 gene and the p53 gene | Q78532808 | ||
| Mutant Wilms' tumor 1 (WT1) mRNA with premature termination codons in acute myeloid leukemia (AML) is sensitive to nonsense-mediated RNA decay (NMD) | Q82269123 | ||
| Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia | Q83244976 | ||
| P433 | issue | 2 | |
| P921 | main subject | leukemia | Q29496 |
| P304 | page(s) | 266-277 | |
| P577 | publication date | 2017-11-23 | |
| P1433 | published in | Haematologica | Q5638209 |
| P1476 | title | WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia | |
| P478 | volume | 103 |
| Q89655650 | Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia |
| Q97522002 | Novel Genetic Variations in Acute Myeloid Leukemia in Pakistani Population |
| Q91743034 | WITER: a powerful method for estimation of cancer-driver genes using a weighted iterative regression modelling background mutation counts |
Search more.